KMID : 1189320180120060992
|
|
Asian Spine Journal 2018 Volume.12 No. 6 p.992 ~ p.997
|
|
Feasibility of Serum Pentosidine Level as a Potential Risk Factor for Osteoporotic Vertebral Compression Fracture
|
|
Choi Dong-Hyuk
Lee Sang-Min Lim Sung-An Choi Yong-Soo
|
|
Abstract
|
|
|
Study Design: Feasibility study.
Purpose: To evaluate the feasibility of using serum pentosidine level as a potential marker for osteoporotic vertebral compression fracture (OVCF).
Overview of Literature: A review of previous studies suggests a negative correlation between serum pentosidine concentration and bone strength. However, it is unclear whether serum pentosidine level might be a potential marker of OVCF in Koreans.
Methods: Forty patients who underwent bone mineral density examination were included in this study, and their serum pentosidine levels were prospectively analyzed. Serum pentosidine level was evaluated using enzyme-linked immunosorbent assay. Among all the patients, 11 with OVCF were assigned to the vertebral fracture group and 29 who did not have vertebral fracture were included in the non-fracture group. In addition, we used the Fracture Risk Assessment (FRAX) tool Korean version for assessing the 10-year probability of fracture.
Results: There was a statistically significant difference in the mean serum pentosidine level (p=0.04) of the vertebral fracture group (110.8 ng/mL) and the non-fracture group (64.3 ng/mL). Logistic regression analyses showed that serum pentosidine was significantly associated with OVCF. The vertebral fracture group had significantly higher 10-year probability of major osteoporotic fracture as per FRAX than the non-fracture group. There was a positive correlation between pentosidine level and FRAX results (r=0.35, p=0.02).
Conclusions: These results suggest that increased serum pentosidine level could be a potential marker for OVCF.
|
|
KEYWORD
|
|
Vertebral compression fracture, Osteoporosis, Pentosidine
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|